Matthew Winkler - Net Worth and Insider Trading
Matthew Winkler Net Worth
The estimated net worth of Matthew Winkler is at least $3 Million dollars as of 2024-11-08. Matthew Winkler is the Director of Akoya Biosciences Inc and owns about 984,513 shares of Akoya Biosciences Inc (AKYA) stock worth over $3 Million. Details can be seen in Matthew Winkler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Winkler has not made any transactions after 2023-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Winkler
Matthew Winkler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Winkler owns 2 companies in total, including Synlogic Inc (SYBX) , and Akoya Biosciences Inc (AKYA) .
Click here to see the complete history of Matthew Winkler’s form 4 insider trades.
Insider Ownership Summary of Matthew Winkler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYBX | Synlogic Inc | 2015-09-30 | director |
| AKYA | Akoya Biosciences Inc | 2023-06-12 | director |
Matthew Winkler Latest Holdings Summary
Matthew Winkler currently owns a total of 1 stock. Matthew Winkler owns 984,513 shares of Akoya Biosciences Inc (AKYA) as of June 12, 2023, with a value of $3 Million.
Latest Holdings of Matthew Winkler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKYA | Akoya Biosciences Inc | 2023-06-12 | 984,513 | 3.24 | 3,187,853 |
Holding Weightings of Matthew Winkler
Matthew Winkler Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Winkler has made a total of 1 transactions in Akoya Biosciences Inc (AKYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akoya Biosciences Inc is the acquisition of 203,388 shares on June 12, 2023, which cost Matthew Winkler around $1 Million.
Insider Trading History of Matthew Winkler
- 1
Matthew Winkler Trading Performance
GuruFocus tracks the stock performance after each of Matthew Winkler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Winkler is -14.89%. GuruFocus also compares Matthew Winkler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Winkler within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Winkler's insider trading performs compared to the benchmark.
Performance of Matthew Winkler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 36.03 | | | | | |
| Relative Return to S&P 500(%) | 32.96 | | | | | |
Matthew Winkler Ownership Network
Ownership Network List of Matthew Winkler
Ownership Network Relation of Matthew Winkler
Matthew Winkler Owned Company Details
What does Synlogic Inc do?
Who are the key executives at Synlogic Inc?
Matthew Winkler is the director of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Matthew Winkler made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .
In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
Matthew Winkler Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Winkler. You might contact Matthew Winkler via mailing address: C/o Mirna Therapeutics, Inc., 2150 Woodward St., Suite 100, Austin Tx 78744.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
